Advanced and experienced hematology and cancer care.
Anemia

Phase 3 study investigating the efficacy and safety of roxadustat for treatment of anemia in patients with lower risk Myelodysplastic Syndrome (MDS) and low Red Blood Cell (RBC) transfusion burden.

By Adam Lingle | Published November 29, 2021 Posted in Clinical Trials | Leave a comment

© 2022 Oncology Specialists of Charlotte

704-342-1900 Main
704-377-0353 Fax
704-342-9577 Appointments

Quick Links
Most Recent Posts
Connect With Us
Subscribe to our Newsletter!

Signup today for free and be the first to get notified on new updates.